Financialsexperimental
BIOMERICA INC (BMRA). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD (whole amounts) · shares (whole numbers) · per-share amounts in USD
| Income Statement | Q1 FY27 31 Aug 2026 | Q4 FY26 31 May 2026 | Q3 FY26 28 Feb 2026 | Q2 FY26 30 Nov 2025 | Q1 FY26 31 Aug 2025 | Q4 FY25 31 May 2025 | Q3 FY25 28 Feb 2025 | Q2 FY25 30 Nov 2024 | Q1 FY25 31 Aug 2024 | Q4 FY24 31 May 2024 | Q3 FY24 29 Feb 2024 | Q2 FY24 30 Nov 2023 | Q1 FY24 31 Aug 2023 | Q4 FY23 31 May 2023 | Q3 FY23 28 Feb 2023 | Q2 FY23 30 Nov 2022 | Q1 FY23 31 Aug 2022 | Q4 FY22 31 May 2022 | Q3 FY22 28 Feb 2022 | Q2 FY22 30 Nov 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 1,265,000 | 875,000* | 987,000 | 1,210,000 | 1,380,000 | 749,000* | 1,119,000 | 1,636,000 | 1,807,000 | 1,116,000* | 1,017,000 | 1,567,000 | 1,713,000 | 1,108,208* | 1,111,442 | 1,481,915 | 1,637,435 | 5,302,221* | 7,660,501 | 4,646,900 |
| Cost of sales | -1,162,000 | -946,000* | -1,031,000 | -1,159,000 | -956,000 | -993,000* | -1,100,000 | -1,199,000 | -1,518,000 | -1,096,000* | -1,166,000 | -1,242,000 | -1,301,000 | -1,079,401* | -991,169 | -1,130,040 | -1,692,390 | -4,680,816* | -5,987,277 | -3,875,141 |
| Gross profit | 103,000 | -71,000* | -44,000 | 51,000 | 424,000 | -244,000* | 19,000 | 437,000 | 289,000 | 20,000* | -149,000 | 325,000 | 412,000 | 28,807* | 120,273 | 351,875 | -54,955 | 621,405* | 1,673,224 | 771,759 |
| Selling, general, and administrative | 1,124,000 | 1,257,000* | 1,076,000 | 1,231,000 | 1,330,000 | 1,068,000* | 1,012,000 | 1,173,000 | 1,360,000 | 1,283,000* | 1,508,000 | 1,521,000 | 1,172,000 | 1,495,745* | 1,379,412 | 1,556,022 | 1,653,821 | 2,080,700* | 1,323,725 | 1,282,998 |
| Research and development | 206,000 | 205,000* | 178,000 | 193,000 | 212,000 | 252,000* | 217,000 | 257,000 | 297,000 | 265,000* | 343,000 | 412,000 | 472,000 | 368,857* | 392,031 | 461,941 | 361,171 | 297,040* | 456,998 | 618,522 |
| Total operating expenses | 1,330,000 | 1,462,000* | 1,254,000 | 1,424,000 | 1,542,000 | 1,320,000* | 1,229,000 | 1,430,000 | 1,657,000 | 1,548,000* | 1,851,000 | 1,933,000 | 1,644,000 | 1,864,602* | 1,771,443 | 2,017,963 | 2,014,992 | 2,377,740* | 1,780,723 | 1,901,520 |
| Loss from operations | -1,227,000 | -1,533,000* | -1,298,000 | -1,373,000 | -1,118,000 | -1,564,000* | -1,210,000 | -993,000 | -1,368,000 | -1,528,000* | -2,000,000 | -1,608,000 | -1,232,000 | -1,835,795* | -1,651,170 | -1,666,088 | -2,069,947 | -1,756,335* | -107,499 | -1,129,761 |
| Dividend and interest income | 55,632* | 36,086 | 41,254 | 28 | 6,899* | 6,019 | 6,916 | |||||||||||||
| Dividend, interest, and other income | 1,000 | 58,000 | 1,123,000 | 25,000* | 43,000 | 40,000 | 56,000 | 114,000* | 86,000 | 109,000 | 123,000 | |||||||||
| Dividend, interest, and other income (loss) | -6,000 | |||||||||||||||||||
| Total other income | 1,000 | 394,000* | -6,000 | 58,000 | 1,123,000 | 25,000* | 43,000 | 40,000 | 56,000 | 114,000* | 86,000 | 109,000 | 123,000 | 28 | ||||||
| (Loss) income before income taxes | -1,226,000 | -1,139,000* | -1,304,000 | -1,315,000 | 5,000 | -1,539,000* | -1,167,000 | -953,000 | -1,312,000 | -1,414,000* | -1,914,000 | -1,499,000 | -1,109,000 | -1,779,163* | -1,615,084 | -1,624,834 | -2,069,919 | -1,749,436* | -101,480 | -1,122,845 |
| Provision for income taxes | -6,000 | -6,000* | -8,000 | -5,000 | -3,000 | -5,000* | 4,000 | 3,000 | -4,000 | -7,000* | -4,000 | -8,000 | -23,000 | -13,014* | -34,775 | -1,254 | -1,957 | -9,585* | -2,688 | -2,429 |
| Net (loss) income | -1,232,000 | -1,145,000* | -1,312,000 | -1,320,000 | 2,000 | -1,544,000* | -1,163,000 | -950,000 | -1,316,000 | -1,421,000* | -1,918,000 | -1,507,000 | -1,132,000 | -1,792,177* | -1,649,859 | -1,626,088 | -2,071,876 | -1,759,021* | -104,168 | -1,125,274 |
| Basic net (loss) income per common share | -0.37 | -0.44 | -0.45 | 0 | -0.06 | -0.06 | -0.08 | -0.11 | -0.09 | -0.07 | -0.12 | -0.12 | -0.16 | -0.01 | -0.09 | |||||
| Diluted net (loss) income per common share | -0.37 | -0.44 | -0.45 | 0 | -0.06 | -0.06 | -0.08 | -0.11 | -0.09 | -0.07 | -0.12 | -0.12 | -0.16 | -0.01 | -0.09 | |||||
| Basic | 3,295,939 | 3,010,308 | 2,908,164 | 2,638,699 | 19,186,282 | 17,121,436 | 16,821,646 | 16,821,646 | 16,821,646 | 16,821,646 | 13,481,490 | 13,455,166 | 13,100,407 | 12,820,481 | 12,592,341 | |||||
| Diluted | 3,295,939 | 3,010,308 | 2,908,164 | 2,638,699 | 19,186,282 | 17,121,436 | 16,821,646 | 16,821,646 | 16,821,646 | 16,821,646 | 13,481,490 | 13,455,166 | 13,100,407 | 12,820,481 | 12,592,341 | |||||
| Foreign currency translation adjustment | -4,000 | -5,000* | 0* | -1,000 | 2,000 | 8,000* | -1,000 | -4,000 | -6,000 | 0* | 2,000 | 0* | 6,000 | 975* | -15,498 | -8,950 | -12,527 | -13,079* | -2,538 | -4,750 |
| Comprehensive (loss) income | -1,236,000 | -1,150,000* | -1,312,000 | -1,321,000 | 4,000 | -1,536,000* | -1,164,000 | -954,000 | -1,322,000 | -1,421,000* | -1,916,000 | -1,507,000 | -1,126,000 | -1,791,202* | -1,665,357 | -1,635,038 | -2,084,403 | -1,772,100* | -106,706 | -1,130,024 |